Showing results (51-60 of 115) with videos related to

Sort By:
Pageof 12
Journal of Clinical Medicine|January 11, 2022
Tocilizumab Trough Levels Variability in Kidney-Transplant Candidates Undergoing DesensitizationAurélie Truffot, Thomas Jouve, Johan Noble, et al.
Frontiers in Medicine|January 10, 2022
Tocilizumab in the Treatment of Chronic Antibody-Mediated Rejection Post Kidney Transplantation: Clinical and Histological MonitoringJohan Noble, Diane Giovannini, Reda Laamech, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|May 18, 2022
Cryoglobulinemia and double-filtration plasmapheresis: Personal experience and literature reviewHamza Naciri Bennani, Augustin Twite Banza, Florian Terrec, et al.
Transplant Immunology|May 10, 2019
Switching renal transplant recipients to belatacept therapy: results of a real-life gradual conversion protocolPaolo Malvezzi, Clara Fischman, Guillaume Rigault, et al.
Clinical Biochemistry|December 31, 2022
Quantification of belatacept by liquid chromatography-tandem mass spectrometry in human plasma: Application to a pharmacokinetic study in renal transplant recipientsAurélie Truffot, Jean-François Jourdil, Elodie Veyret-Gautier, et al.
Journal of Clinical Apheresis|March 30, 2021
Fibrinogen reconstitution after therapeutic apheresis: Comparison of double-filtration plasmapheresis, plasma exchange, and immunoadsorptionThomas Jouve, Raphaël Marlu, Hamza Naciri Bennani, et al.
Journal of Clinical Medicine|August 27, 2021
Protocol Biopsies on de novo Renal-Transplants at 3 Months after Surgery: Impact on 5-Year Transplant SurvivalFlorian Terrec, Johan Noble, Hamza Naciri-Bennani, et al.
Transplantation Direct|February 13, 2020
Late Conversion From Calcineurin Inhibitors to Belatacept in Kidney-Transplant Recipients Has a Significant Beneficial Impact on Glycemic ParametersFlorian Terrec, Thomas Jouve, Hamza Naciri-Bennani, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|October 23, 2018
Systematic Screening Using Luminex for De Novo C3d Fixing of Class II Donor-Specific Antibodies Is Correlated With Luminex Mean Fluorescence Intensity in Renal Transplant PatientsMorgane Villemaire, Thomas Jouve, Anne Bourdin, et al.
Transplantation Proceedings|November 17, 2019
Early Prediction of Graft Outcomes After Kidney Transplantation From Donors After Circulatory Death: Biomarkers and Transplantation CharacteristicsAnne-Sophie Truche, Candice Trocme, Sabrina Vergnaud, et al.
Pageof 12